Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Investigational New Drugs|June 23, 2018
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2Tomoko Takimoto-Shimomura, Taku Tsukamoto, Saori Maegawa, et al.
Cancer Genomics & Proteomics|April 27, 2018
Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant SublineTomoko Takimoto-Shimomura, Hisao Nagoshi, Saori Maegawa, et al.
International Journal of Hematology|March 5, 2019
A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphomaYoshimi Mizuno, Yoshiaki Chinen, Taku Tsukamoto, et al.
Experimental Hematology|March 8, 2020
Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalitiesYoshiaki Chinen, Taku Tsukamoto, Saori Maegawa-Matsui, et al.
International Journal of Hematology|October 23, 2020
EWSR1 overexpression is a pro-oncogenic event in multiple myelomaDaichi Nishiyama, Yoshiaki Chinen, Reiko Isa, et al.
Cancer Medicine|May 19, 2020
Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphomaYayoi Matsumura-Kimoto, Taku Tsukamoto, Yuji Shimura, et al.
International Journal of Molecular Sciences|March 25, 2022
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple MyelomaReiko Isa, Mano Horinaka, Taku Tsukamoto, et al.
Cancers|August 13, 2020
Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple MyelomaYuto Fujibayashi, Reiko Isa, Daichi Nishiyama, et al.
British Journal of Haematology|June 20, 2020
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myelomaSaeko Kuwahara-Ota, Yuji Shimura, Christian Steinebach, et al.
Cancer Medicine|February 24, 2018
Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapyYoshimi Mizuno, Taku Tsukamoto, Eri Kawata, et al.
Pageof 2